MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.

MLA

Lubinski, Jan, et al. “MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.” JAMA Oncology, vol. 10, no. 4, Apr. 2024, pp. 493–99. EBSCOhost, https://doi.org/10.1001/jamaoncol.2023.6944.

APA

Lubinski, J., Kotsopoulos, J., Moller, P., Pal, T., Eisen, A., Peck, L., Karlan, B. Y., Aeilts, A., Eng, C., Bordeleau, L., Foulkes, W. D., Tung, N., Couch, F. J., Fruscio, R., Ramon Y Cajal, T., Singer, C. F., Neuhausen, S. L., Zakalik, D., Cybulski, C., … Narod, S. A. (2024). MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations. JAMA Oncology, 10(4), 493–499. https://doi.org/10.1001/jamaoncol.2023.6944

Chicago

Lubinski, Jan, Joanne Kotsopoulos, Pal Moller, Tuya Pal, Andrea Eisen, Larissa Peck, Beth Y Karlan, et al. 2024. “MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.” JAMA Oncology 10 (4): 493–99. doi:10.1001/jamaoncol.2023.6944.